Back/KORU Medical Systems Advances Patient-Centric Care with Innovative Infusion Solutions
medical·November 9, 2024·krmd

KORU Medical Systems Advances Patient-Centric Care with Innovative Infusion Solutions

ED
Editorial
Cashu Finance·3 min read
TL;DR
  • KORU Medical Systems develops innovative subcutaneous infusion solutions to enhance patient quality of life at home and in clinics.
  • The FREEDOM Syringe Infusion System, including FREEDOM60® and FreedomEdge®, supports self-administration and professional use in patient care.
  • KORU Medical prioritizes education and resources for patients and healthcare professionals, fostering an informed community around its therapies.

KORU Medical Systems Strengthens Commitment to Patient-Centric Care Through Innovative Infusion Solutions

KORU Medical Systems, a medical technology company based in Mahwah, New Jersey, is dedicated to enhancing patient quality of life through the development of innovative subcutaneous infusion solutions. Central to its offerings is the FREEDOM Syringe Infusion System, which includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, along with the Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. This system, which received FDA clearance in 1994, is tailored for both self-administration by patients at home and use in ambulatory infusion centers by healthcare professionals. By enabling patients to manage their treatments in a comfortable and familiar environment, KORU Medical positions itself as a leader in patient-centric healthcare solutions.

The company’s focus on innovation is evident through its Novel Therapies division, which collaborates with biopharmaceutical firms to provide customizable solutions for clinical trials and drug development. This division is particularly vital as it supports the evolving landscape of medical treatments and therapies, ensuring that KORU Medical remains at the forefront of technological advancements in the infusion market. By offering versatile and reliable infusion solutions, KORU Medical not only aids in patient care but also plays a significant role in the development of new therapeutic agents, thus contributing to the overall improvement of healthcare outcomes.

KORU Medical's participation in significant investor conferences, such as the 15th Annual Craig-Hallum Alpha Select Conference and the Canaccord MedTech, Diagnostics, and Digital Health & Services Forum, underscores its commitment to maintaining engagement with industry stakeholders. These conferences present an opportunity for KORU Medical to showcase its innovations, share insights on patient-centric care, and highlight its contributions to the medical technology sector. As the company continues to expand its presence and influence, it remains focused on its mission to improve patient quality of life through advanced medical solutions.

In addition to its innovative products, KORU Medical emphasizes the importance of education and resources for patients and healthcare professionals alike. The company encourages visitors to its website for more information on its offerings and to stay updated on developments in the field of subcutaneous infusion therapy. By fostering an informed community, KORU Medical aims to enhance the overall experience of those who rely on its products for their treatment.

As KORU Medical Systems advances its initiatives and participates in key industry events, it reinforces its role as a pivotal player in the medical technology landscape, dedicated to transforming patient care through innovation.